Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin Structure Infections.

Open forum infectious diseases·2026
Same author

Reflections on FDA Draft Guidance on Bayesian Methods in Trials-Protecting Scientific Integrity and Evidentiary Standards.

JAMA·2026
Same author

Development of a Kidney Transplant-Specific DOOR for Urinary Tract Infections Assessing the Impact of Carbapenem Resistance.

Transplant infectious disease : an official journal of the Transplantation Society·2026
Same author

Patient-Centric Pragmatic Clinical Trials: Opening the DOOR.

Statistics in medicine·2026
Same author

A patient-centric paradigm and tool for clinical research: the DOOR is open.

Antimicrobial agents and chemotherapy·2025
Same author

Study protocol for a multicenter, multinational prospective randomized controlled trial comparing outcomes in subjects with Gram-negative bacteremia who have blood culture evaluation using Fast Antibiotic Susceptibility Testing vs. standard of care testing: the FAST trial.

Trials·2025
Same journal

Acute bioenergetic intervention or pharmacological preconditioning protects neuron against ischemic injury.

Journal of experimental stroke & translational medicine·2013
Same journal

Strategies for therapeutic hypometabothermia.

Journal of experimental stroke & translational medicine·2013
Same journal

Chemokine receptor-like 2 is involved in ischemic brain injury.

Journal of experimental stroke & translational medicine·2013
Same journal

Long-term survival and serial assessment of stroke damage and recovery - practical and methodological considerations.

Journal of experimental stroke & translational medicine·2012
Same journal

Targeting ischemic penumbra Part II: selective drug delivery using liposome technologies.

Journal of experimental stroke & translational medicine·2011
Same journal

Fundamentals of clinical trial design.

Journal of experimental stroke & translational medicine·2011
See all related articles

Related Experiment Video

Updated: Jun 3, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Common statistical concerns in clinical trials.

Scott R Evans1

  • 1Department of Statistics, Harvard University, Boston, MA.

Journal of Experimental Stroke & Translational Medicine
|March 23, 2011
PubMed
Summary
This summary is machine-generated.

Understanding statistics is crucial for effective clinical trial design, data monitoring, analysis, and reporting. Clinicians with strong statistical knowledge enhance trial quality and comprehension.

More Related Videos

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

Related Experiment Videos

Last Updated: Jun 3, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Medical Research

Background:

  • Statistics are fundamental to all phases of clinical trials, including design, monitoring, analysis, and reporting.
  • A strong grasp of statistical principles by clinicians is essential for improving trial comprehension and overall quality.

Purpose of the Study:

  • To outline key statistical concepts relevant to clinicians involved in clinical trials.
  • To enhance clinicians' understanding of statistical considerations in trial conduct.

Main Methods:

  • This manuscript reviews common statistical issues encountered in clinical trials.
  • Focuses on providing essential statistical knowledge for medical practitioners.

Main Results:

  • Clinicians' statistical understanding directly impacts the quality and interpretation of clinical trial data.
  • Familiarity with statistical concepts aids in critical evaluation of trial methodologies and outcomes.

Conclusions:

  • Educating clinicians on statistical concepts is vital for advancing the quality and integrity of clinical research.
  • Improved statistical literacy among clinicians leads to more robust and reliable clinical trial outcomes.